Indication fruzaqla is indicated for the treatment of adult patients with metastatic colorectal cancer (mcrc) who have been previously treated with fluoropyrimidine‐, oxaliplatin‐, and … Fruzaqla® is an oral medication for people with previously treated metastatic colorectal cancer that can be taken after chemotherapy and certain anti-cancer medicines. See important safety info.

Fruzaqla® (fru-zahk-la) (fruquintinib) capsules what is fruzaqla? Fruzaqla is a prescription medicine used to treat adults with colon or rectal cancer that has spread to other parts of the body … Fruquintinib is also called fruzaqla®. It is a type of targeted therapy drug called an angiogenesis inhibitor. Fruquintinib blocks a protein called vascular endothelial growth factor receptor (vegfr). Medscape - colorectal cancer dosing for fruzaqla (fruquintinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.

Fruquintinib blocks a protein called vascular endothelial growth factor receptor (vegfr). Medscape - colorectal cancer dosing for fruzaqla (fruquintinib), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.